Market cap growth surges for over half of the top biopharmaceutical companies in 2022
Pharmaceutical Technology
FEBRUARY 8, 2023
The 13 top players experienced significant growth over 2022 despite the decline in demand for COVID-19 vaccines and therapeutics, as well as uncertainty surrounding pricing due to the newly passed Inflation Reduction Act in the US. billion on Dec 31, 2022. Merck & Co. Merck & Co. billion to $281.3 to $365.84.
Let's personalize your content